http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2683148-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c9d413166cd8c14fa898933636977cef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40b83d881ab0514072b9ad1360acdea7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate 1992-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7558d3070371b581c33aacf34ad62ebd
publicationDate 1993-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2683148-A1
titleOfInvention PHARMACEUTICAL PRODUCTS FOR TREATING TUMOR DISEASES AND PROCESS FOR PREPARING THE SAME.
abstract The present invention relates to products for curing tumor diseases, comprising as active component water or aqueous solutions suitable for human consumption, having a deuterium content of 0.1 to 110 ppm, optionally with carriers and / or adjuvants, in the form of pharmaceuticals or medicinal solutions. In addition, the invention provides a process for preparing these products.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BE-1009622-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9525526-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016001643-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2717682-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9603996-A1
priorityDate 1991-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8901342-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0283139-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID15461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3265
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396229
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100298939
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID293621
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID550286
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID466302
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167583
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559591

Total number of triples: 37.